C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5243-5252

  Zhang, Lin ^a   Liu, Shan Hui ^a   Wright, Tyler T ^b   Shen, Zhi Yuan ^a   Li, Hai Yun ^a   Zhu, Wei ^a   Potempa, Lawrence A ^c   Ji, Shang Rong ^a   Szalai, Alexander J ^b   Wu, Yi ^a  

^a LANZHOU UNIVERSITY   (China)

^b University of Alabama at Birmingham   (United States)

^c ROOSEVELT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; STAT1 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN BINDING;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; JURKAT CELL LINE; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; ANIMALS; C-REACTIVE PROTEIN; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN BINDING; TH1 CELLS; TH2 CELLS;

EID: 84929625543     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402909     Document Type: Article

References (54)

1. Pepys, M. B., and G. M. Hirschfield. 2003. C-reactive protein: a critical update. J. Clin. Invest. 111: 1805-1812.
2. Ma, X., S. R. Ji, and Y. Wu. 2013. Regulated conformation changes in C-reactive protein orchestrate its role in atherogenesis. Chin. Sci. Bull. 58: 1642-1649.
3. Bottazzi, B., A. Doni, C. Garlanda, and A. Mantovani. 2010. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu. Rev. Immunol. 28: 157-183.
4. Du Clos, T. W. 2013. Pentraxins: structure, function, and role in inflammation. ISRN Inflamm 2013: 379040.
5. Szalai, A. J., C. T. Weaver, M. A. McCrory, F. W. van Ginkel, R. M. Reiman, J. F. Kearney, T. N. Marion, and J. E. Volanakis. 2003. Delayed lupus onset in (NZB 3 NZW)F1 mice expressing a human C-reactive protein transgene. Arthritis Rheum. 48: 1602-1611.
6. Hu, X. Z., T. T. Wright, N. R. Jones, T. N. Ramos, G. A. Skibinski, M. A. McCrory, S. R. Barnum, and A. J. Szalai. 2011. Inhibition of experimental autoimmune encephalomyelitis in human C-reactive protein transgenic mice is FcgRIIB dependent. Autoimmune Dis. 2011: 484936.
7. Szalai, A. J., S. Nataf, X. Z. Hu, and S. R. Barnum. 2002. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J. Immunol. 168: 5792-5797.
8. Jones,N.R., M. A. Pegues,M.A. McCrory, S.W. Kerr, H. Jiang,R. Sellati,V. Berger, J. Villalona, R. Parikh, M. McFarland, et al. 2011. Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice. Arthritis Rheum. 63: 2641-2650.
9. Wang, M. Y., H. H. Zhou, S. C. Zhang, F. Hui, W. Zhu, H. X. Su, H. Y. Guo, X. W. Li, S. R. Ji, and Y. Wu. 2014. Recurrent mutations at C-reactive protein gene promoter SNP position 2286 in human cancers. Cell Res. 24: 505-508.
10. Su, H. X., H. H. Zhou, M. Y. Wang, J. Cheng, S. C. Zhang, F. Hui, X. Z. Chen, S. H. Liu, Q. J. Liu, Z. J. Zhu, et al. 2014. Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk. PLoS ONE 9: e102418.
11. Pepper, M., and M. K. Jenkins. 2011. Origins of CD4+ effector and central memory T cells. Nat. Immunol. 12: 467-471.
12. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393-407.
13. Stohl, W. 2013. Future prospects in biologic therapy for systemic lupus erythematosus. Nat. Rev. Rheumatol. 9: 705-720.
14. Alzabin, S., and R. O. Williams. 2011. Effector T cells in rheumatoid arthritis: lessons from animal models. FEBS Lett. 585: 3649-3659.
15. Holgate, S. T. 2012. Innate and adaptive immune responses in asthma. Nat. Med. 18: 673-683.
16. Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
17. Zhu, J., and W. E. Paul. 2008. CD4 T cells: fates, functions, and faults. Blood 112: 1557-1569.
18. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
19. Mills, K. H. 2011. TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 11: 807-822.
20. Imanishi, T., H. Hara, S. Suzuki, N. Suzuki, S. Akira, and T. Saito. 2007. Cutting edge: TLR2 directly triggers Th1 effector functions. J. Immunol. 178: 6715-6719.
21. Reynolds, J. M., B. P. Pappu, J. Peng, G. J. Martinez, Y. Zhang, Y. Chung, L. Ma, X. O. Yang, R. I. Nurieva, Q. Tian, and C. Dong. 2010. Toll-like receptor 2 signaling in CD4+ T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 32: 692-702.
22. Croft, S. M., R. F. Mortensen, and H. Gewurz. 1976. Binding of C-reactive protein to antigen-induced but not mitogen-induced T lymphoblasts. Science 193: 685-687.
23. Mortensen, R. F., and H. Gewurz. 1976. Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes. J. Immunol. 116: 1244-1250.
24. Mortensen, R. F., A. P. Osmand, and H. Gewurz. 1975. Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions. J. Exp. Med. 141: 821-839.
25. James, K., B. Hansen, and H. Gewurz. 1981. Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity. J. Immunol. 127: 2539-2544.
26. Marnell, L. L., C. Mold, M. A. Volzer, R. W. Burlingame, and T. W. Du Clos. 1995. C-reactive protein binds to Fc gamma RI in transfected COS cells. J. Immunol. 155: 2185-2193.
27. Bharadwaj, D., M. P. Stein, M. Volzer, C. Mold, and T. W. Du Clos. 1999. The major receptor for C-reactive protein on leukocytes is Fcg receptor II. J. Exp. Med. 190: 585-590.
28. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcg receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
29. Fujita, Y., A. Kakino, N. Nishimichi, S. Yamaguchi, Y. Sato, S. Machida, L. Cominacini, Y. Delneste, H. Matsuda, and T. Sawamura. 2009. Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects. Clin. Chem. 55: 285-294.
30. Ciliberto, G., R. Arcone, E. F. Wagner, and U. Rüther. 1987. Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J. 6: 4017-4022.
31. Taylor, K. E., and C. W. van den Berg. 2007. Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein. Immunology 120: 404-411.
32. Ji, S. R., Y. Wu, L. Zhu, L. A. Potempa, F. L. Sheng, W. Lu, and J. Zhao. 2007. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm. FASEB J. 21: 284-294.
33. Ying, S. C., H. Gewurz, C. M. Kinoshita, L. A. Potempa, and J. N. Siegel. 1989. Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. J. Immunol. 143: 221-228.
34. Gershov, D., S. Kim, N. Brot, and K. B. Elkon. 2000. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192: 1353-1364.
35. Moriwaki, H., N. Kume, T. Sawamura, T. Aoyama, H. Hoshikawa, H. Ochi, E. Nishi, T. Masaki, and T. Kita. 1998. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 18: 1541-1547.
36. Smeets, R. L., W. W. Fleuren, X. He, P. M. Vink, F. Wijnands, M. Gorecka, H. Klop, S. Bauerschmidt, A. Garritsen, H. J. Koenen, et al. 2012. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. BMC Immunol. 13: 12.
37. Kawashima, H., and M. Fukuda. 2012. Sulfated glycans control lymphocyte homing. Ann. N. Y. Acad. Sci. 1253: 112-121.
38. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16: 495-521.
39. Nelms, K., A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17: 701-738.
40. Lu, Y., B. Chen, J. H. Song, T. Zhen, B. Y. Wang, X. Li, P. Liu, X. Yang, Q. L. Zhang, X. D. Xi, et al. 2013. Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells. Proc. Natl. Acad. Sci. USA 110: 2258-2263.
41. Yang, Y., J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke, and A. E. Lovett-Racke. 2009. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206: 1549-1564.
42. Li, D., G. Romain, A. L. Flamar, D. Duluc, M. Dullaers, X. H. Li, S. Zurawski, N. Bosquet, A. K. Palucka, R. Le Grand, et al. 2012. Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J. Exp. Med. 209: 109-121.
43. Hart, S. P., K. M. Alexander, S. M. MacCall, and I. Dransfield. 2005. C-reactive protein does not opsonize early apoptotic human neutrophils, but binds only membrane-permeable late apoptotic cells and has no effect on their phagocytosis by macrophages. J. Inflamm. (Lond.) 2: 5.
44. Van Vré, E. A., H. Bult, V. Y. Hoymans, V. F. Van Tendeloo, C. J. Vrints, and J. M. Bosmans. 2008. Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation. Arterioscler. Thromb. Vasc. Biol. 28: 511-518.
45. Thomas-Rudolph, D., T. W. Du Clos, C. M. Snapper, and C. Mold. 2007. C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to FcgR on dendritic cells. J. Immunol. 178: 7283-7291.
46. Mold, C., W. Rodriguez, B. Rodic-Polic, and T. W. Du Clos. 2002. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcgR. J. Immunol. 169: 7019-7025.
47. Mold, C., and T. W. Du Clos. 2006. C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fcg receptors. J. Immunol. 176: 7598-7604.
48. Rodriguez, W., C. Mold, M. Kataranovski, J. Hutt, L. L. Marnell, and T. W. Du Clos. 2005. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum. 52: 642-650.
49. Qian, B. Z., and J. W. Pollard. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
50. Jones, N. R., M. A. Pegues, M. A. McCrory, W. Singleton, C. Bethune, B. F. Baker, D. A. Norris, R. M. Crooke, M. J. Graham, and A. J. Szalai. 2012. A selective inhibitor of human C-reactive protein translation is efficacious in vitro and in C-reactive protein transgenic mice and humans. Mol Ther Nucleic Acids 1: e52.
51. Lane, T., N. Wassef, S. Poole, Y. Mistry, H. J. Lachmann, J. D. Gillmore, P. N. Hawkins, and M. B. Pepys. 2014. Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteers. Circ. Res. 114: 672-676.
52. Eisenhardt, S. U., J. R. Thiele, H. Bannasch, G. B. Stark, and K. Peter. 2009. C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle 8: 3885-3892.
53. Wang, M. Y., S. R. Ji, C. J. Bai, D. El Kebir, H. Y. Li, J. M. Shi, W. Zhu, S. Costantino, H. H. Zhou, L. A. Potempa, et al. 2011. A redox switch in C-reactive protein modulates activation of endothelial cells. FASEB J. 25: 3186-3196.
54. Li, H. Y., J. Wang, Y. X. Wu, L. Zhang, Z. P. Liu, J. G. Filep, L. A. Potempa, Y. Wu, and S. R. Ji. 2014. Topological localization of monomeric C-reactive protein determines proinflammatory endothelial cell responses. J. Biol. Chem. 289: 14283-14290.